12/2
07:10 am
gmed
Globus Medical (NYSE:GMED) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Low
Report
Globus Medical (NYSE:GMED) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
11/28
02:23 am
gmed
How the Narrative Around Globus Medical Is Evolving After Recent Analyst and Market Updates [Yahoo! Finance]
Low
Report
How the Narrative Around Globus Medical Is Evolving After Recent Analyst and Market Updates [Yahoo! Finance]
11/20
11:56 pm
gmed
A Look at Globus Medical (GMED) Valuation Following Its Recent 31% Share Price Rebound [Yahoo! Finance]
Medium
Report
A Look at Globus Medical (GMED) Valuation Following Its Recent 31% Share Price Rebound [Yahoo! Finance]
11/18
02:23 pm
gmed
10 Years Later: 5 Lesser-Known Rule Breakers [Yahoo! Finance]
Low
Report
10 Years Later: 5 Lesser-Known Rule Breakers [Yahoo! Finance]
11/18
08:41 am
gmed
Globus Medical (NYSE:GMED) had its "buy" rating reaffirmed by analysts at Truist Financial Corporation. They now have a $105.00 price target on the stock, up previously from $93.00.
Low
Report
Globus Medical (NYSE:GMED) had its "buy" rating reaffirmed by analysts at Truist Financial Corporation. They now have a $105.00 price target on the stock, up previously from $93.00.
11/16
11:45 pm
gmed
Should Investors Reassess Globus Medical After 41% One Month Surge and M&A News? [Yahoo! Finance]
Low
Report
Should Investors Reassess Globus Medical After 41% One Month Surge and M&A News? [Yahoo! Finance]
11/16
01:09 am
gmed
11/14
06:30 pm
gmed
Globus Medical (GMED) is an Incredible Growth Stock: 3 Reasons Why [Yahoo! Finance]
Low
Report
Globus Medical (GMED) is an Incredible Growth Stock: 3 Reasons Why [Yahoo! Finance]
11/14
10:23 am
gmed
Medical Products Leader In Base After 36% Stock Surge On Blowout Quarterly Earnings [Yahoo! Finance]
Low
Report
Medical Products Leader In Base After 36% Stock Surge On Blowout Quarterly Earnings [Yahoo! Finance]
11/12
06:43 am
gmed
Globus Medical (NYSE:GMED) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Low
Report
Globus Medical (NYSE:GMED) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
11/11
10:08 am
gmed
Globus Medical: Straightening Its Back [Seeking Alpha]
Low
Report
Globus Medical: Straightening Its Back [Seeking Alpha]
11/10
01:48 pm
gmed
Globus Medical (NYSE:GMED) had its price target raised by analysts at Barclays PLC from $106.00 to $114.00. They now have an "overweight" rating on the stock.
Low
Report
Globus Medical (NYSE:GMED) had its price target raised by analysts at Barclays PLC from $106.00 to $114.00. They now have an "overweight" rating on the stock.
11/9
07:03 pm
gmed
Globus Medical, Inc. Just Recorded A 18% EPS Beat: Here's What Analysts Are Forecasting Next [Yahoo! Finance]
Low
Report
Globus Medical, Inc. Just Recorded A 18% EPS Beat: Here's What Analysts Are Forecasting Next [Yahoo! Finance]
11/9
01:13 pm
gmed
Globus Medical (GMED) Soars 38.9% on Stellar Q3 [Yahoo! Finance]
Low
Report
Globus Medical (GMED) Soars 38.9% on Stellar Q3 [Yahoo! Finance]
11/8
11:43 pm
gmed
Why Globus Medical (GMED) Is Up 38.9% After Raising 2025 Outlook on Strong Q3 and Nevro Synergies [Yahoo! Finance]
Low
Report
Why Globus Medical (GMED) Is Up 38.9% After Raising 2025 Outlook on Strong Q3 and Nevro Synergies [Yahoo! Finance]
11/7
02:22 pm
gmed
Globus Medical (NYSE:GMED) had its price target raised by analysts at Wells Fargo & Company from $66.00 to $79.00. They now have an "overweight" rating on the stock.
Low
Report
Globus Medical (NYSE:GMED) had its price target raised by analysts at Wells Fargo & Company from $66.00 to $79.00. They now have an "overweight" rating on the stock.
11/7
02:22 pm
gmed
Globus Medical (NYSE:GMED) had its price target raised by analysts at Royal Bank Of Canada from $88.00 to $92.00. They now have an "outperform" rating on the stock.
Low
Report
Globus Medical (NYSE:GMED) had its price target raised by analysts at Royal Bank Of Canada from $88.00 to $92.00. They now have an "outperform" rating on the stock.
11/7
08:07 am
gmed
Globus Medical (NYSE:GMED) was upgraded by analysts at Truist Financial Corporation from a "hold" rating to a "buy" rating. They now have a $93.00 price target on the stock, up previously from $65.00.
Medium
Report
Globus Medical (NYSE:GMED) was upgraded by analysts at Truist Financial Corporation from a "hold" rating to a "buy" rating. They now have a $93.00 price target on the stock, up previously from $65.00.
11/7
08:07 am
gmed
Globus Medical (NYSE:GMED) was upgraded by analysts at Bank of America Corporation from a "neutral" rating to a "buy" rating. They now have a $91.00 price target on the stock, up previously from $65.00.
Medium
Report
Globus Medical (NYSE:GMED) was upgraded by analysts at Bank of America Corporation from a "neutral" rating to a "buy" rating. They now have a $91.00 price target on the stock, up previously from $65.00.
11/6
09:57 pm
gmed
Globus Medical, Inc. (GMED) Q3 2025 Earnings Call Transcript [Seeking Alpha]
Low
Report
Globus Medical, Inc. (GMED) Q3 2025 Earnings Call Transcript [Seeking Alpha]
11/6
05:17 pm
gmed
Globus Medical's (NYSE:GMED) Q3: Strong Sales, Stock Jumps 19.2% [Yahoo! Finance]
Medium
Report
Globus Medical's (NYSE:GMED) Q3: Strong Sales, Stock Jumps 19.2% [Yahoo! Finance]
11/6
04:15 pm
gmed
Globus Medical Reports Third Quarter 2025 Results
High
Report
Globus Medical Reports Third Quarter 2025 Results
11/4
01:27 pm
gmed
Globus Medical (GMED): Assessing Valuation After Recent Share Price Uptick [Yahoo! Finance]
Low
Report
Globus Medical (GMED): Assessing Valuation After Recent Share Price Uptick [Yahoo! Finance]
10/28
08:04 am
gmed
Globus Medical (NYSE:GMED) is now covered by analysts at Stifel Nicolaus. They set a "hold" rating and a $64.00 price target on the stock.
Low
Report
Globus Medical (NYSE:GMED) is now covered by analysts at Stifel Nicolaus. They set a "hold" rating and a $64.00 price target on the stock.
10/16
04:30 pm
gmed
Globus Medical Schedules Third Quarter Earnings Release and Conference Call
Low
Report
Globus Medical Schedules Third Quarter Earnings Release and Conference Call